Stockreport

AVEO Oncology Announces Initiation of Topline Analysis of Phase 3 TIVO-3 Trial

AVEO Pharmaceuticals, Inc.  (AVEO) 
Last aveo pharmaceuticals, inc. earnings: 3/16 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.aveooncology.com
PDF - Analysis Initiated on the Unanimous Recommendation of the TIVO-3 Study Independent Steering Committee - - Company Expects to Report Topline Res [Read more]